Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1426 to 1440 of 1467 results for pathway

  1. More evidence needed to recommend Type 2 diabetes treatment tirzepatide

    More evidence is needed on the clinical and cost-effectiveness of a new treatment option for people with type 2 diabetes before it could be recommended for NHS use, a NICE committee has said.

  2. One-stop-shop for AI and digital regulations for health and social care launched

    New online advice service launched to help the NHS and wider care system adopt and make use of new digital and artificial intelligence

  3. Supporting the NHS's ambition for virtual wards

    An early introduction to NICE’s ongoing activity in virtual wards

  4. NICE continues to support patient access to innovative treatments

    Ahead of an appearance at a King’s Fund event, NICE chairman, Sharmila Nebhrajani, discusses how NICE continues to support patient access to innovative treatments.

  5. NICE is gearing up for the evaluation of further digital health technologies as pilot project produces first result

    Following the successful evaluation of Zio XT, developers of digital health technologies are encouraged to engage with NICE through one of several different routes

  6. Lessons learned from the multi-agency advisory service – helping developers of AI and data-driven tech to navigate the regulatory pathway

    Clíodhna Ní Ghuidhir and Rebecca Boffa outline the common challenges that developers of artificial intelligence (AI) tech face when navigating their way to the health and care market, and link to their series of articles, which provide further advice on what can be done to avoid these.

  7. Putting user-needs at the heart of a multi-agency advisory service for artificial intelligence and data-driven technologies

    Toni Gasse explains how user-needs are being placed front and centre to develop a multi-agency advisory service for artificial intelligence and data-driven technologies.

  8. A refreshed Evidence Standards Framework for Digital Health Technologies and an increased focus on digital health for NICE

    Two exciting developments which will accelerate NICE’s efforts to deliver innovation to the health and care system faster.

  9. Improve community health through walking, cycling and behaviour change

    Improving the health of local populations through encouraging more walking and cycling and by challenging unhealthy behaviours are among the aims of NICE?s latest set of local government public health briefings.

  10. Improved agreement means NICE now recommends lung cancer treatment

    Thousands of people with non-small-cell lung cancer (NSCLC) will benefit from draft guidance published today by NICE.

  11. Innovative approach that gets patients back into their own homes after hospital stay honoured

    Newly introduced programme allowed those in hospital to reduce their length of stay by an average of six days

  12. New LSE master's degree in Evaluation of Health Care Interventions and Outcomes

    NICE is collaborating with the London School of Economics and Political Science (LSE) to develop an executive master’s degree in health care decision-making.

  13. Make use of community pharmacists' skills, says NICE

    Community pharmacy teams have the potential to play a greater role in health promotion and prevention says NICE, in a new draft quality standard.

  14. NICE announces details of health technology evaluation methods review

    Following approval at its recent Board meeting NICE has confirmed the details of its review of the methods it uses to develop guidance on drugs, medical devices and diagnostics.

  15. New NICE quality standard identifies improvements in UTI diagnosis for women

    Health professionals should diagnose women under 65 with a urinary tract infection (UTI) if they have two or more key urinary symptoms according to a new quality standard published by NICE today (15 February 2023).